CompoAtlas

Adrusen Plus

Food supplement declared in France, declaration No 2018-1-509, decision dated 19 January 2018

Adrusen Plus is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
SIFI S.p.A.
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Capsule
Daily dose
1 capsule
Directions for use
une capsule par jour, avec un peu d'eau et avec l'estomac plein.
Not recommended for (according to the manufacturer)
Enfants en bas âge (1 à 3 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Antioxydant, Œil / Vision

Declaration 285708, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
Huile de poissonnot declared
Lutéinenot declared
Astaxanthinenot declared
Lécithinenot declared
Zéaxanthinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Sulfate de cuivreCuivre5,000 µg2,000 µg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Oxyde de zincZinc25 mg15 mg

Additives

E422, E171, E141, E172

Other ingredients

huile de soja, gélatine

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line